Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015049 |
---|---|
Receipt number | R000017483 |
Scientific Title | Phase 2 trial of eribulin/S-1 combination therapy for advanced/recurrent breast cancer |
Date of disclosure of the study information | 2014/09/05 |
Last modified on | 2016/06/02 13:15:10 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/09/04 11:14:57 | ||
2 | Update | 2016/06/02 13:13:35 | Recruitment status Last follow-up date |
|
3 | Update | 2016/06/02 13:15:10 | Name of primary person or sponsor Organization |